Drug lobby protests generic replacement language for EHRs

01/28/2013 | Elsevier Business Intelligence

The Pharmaceutical Research and Manufacturers of America says proposed stage 3 meaningful use rules for EHRs could lead to substitution of a chemically different drug rather than simple generic substitution.

View Full Article in:

Elsevier Business Intelligence